BIOT Stock Price, Chart, Stats & News

L&G Pharma Breakthrough UCITS ETF
Save
L&G Pharma Breakthrough UCITS ETF (BIOT) does not currently pay a dividend.
–
Category
0.49%
Expense ratio
–
Assets
8.52%
1Y return
BIOT chart
About
The L&G Pharma Breakthrough UCITS ETF is designed to mirror the financial performance generated by the Solactive Pharma Breakthrough Value Index.
Top 10 BIOT holdings
| Holding | Ownership |
|---|---|
Health care 3.22% | |
Health care 2.95% | |
Health care 2.93% | |
Health care 2.82% | |
Health care 2.76% | |
Health care 2.75% | |
Health care 2.62% | |
Health care 2.54% | |
Health care 2.52% | |
Health care 2.52% |
Similar securities
Based on sector and market capitalization
Report issue















